Illumina selected to help bring precision medicine into everyday healthcare in Singapore

Illumina selected to help bring precision medicine into everyday healthcare in Singapore

SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in...

QIAGEN Supports Singapore’s National Precision Medicine Program With Sample Preparation

QIAGEN announced that its QIAsprint Connect and QIAseq FX DNA Library Kit will support automated DNA extraction and library preparation for the SG-INSIGHT study, a cohort under Phase III of Singapore’s National Precision Medicine (NPM) program, as part of a consortium led by Singapore-based precision oncology leader Lucence alongside sequencing pioneer Ultima Genomics. Coordinated by Precision Health Research, Singapore (PRECISE), NPM Phase III …

Illumina selected to help bring precision medicine into everyday healthcare

SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore’s healthcare system SINGAPORE – Media OutReach Newswire – 3 November 2026 – Illumina, Inc. (Nasdaq: ILMN) today announced it has been selected to provide whole-genome sequencing services for the […]